HighVista Strategies’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.32M | Buy |
5,781
+2,121
| +58% | +$475K | 0.37% | 89 |
|
|
2025
Q4 | $780K | Sell |
3,660
-3,422
| -48% | -$707K | 0.2% | 123 |
|
|
2025
Q3 | $1.41M | Buy |
7,082
+4,108
| +138% | +$766K | 0.35% | 91 |
|
|
2025
Q2 | $513K | Sell |
2,974
-3,098
| -51% | -$505K | 0.19% | 126 |
|
|
2025
Q1 | $946K | Hold |
6,072
| – | – | 0.36% | 115 |
|
|
2024
Q4 | $836K | Buy |
+6,072
| New | +$798K | 0.31% | 108 |
|
|
2024
Q3 | – | Sell |
-4,527
| Closed | -$617K | – | 144 |
|
|
2024
Q2 | $617K | Hold |
4,527
| – | – | 0.23% | 113 |
|
|
2024
Q1 | $684K | Buy |
4,527
+1,699
| +60% | +$242K | 0.24% | 107 |
|
|
2023
Q4 | $356K | Sell |
2,828
-3,070
| -52% | -$306K | 0.13% | 122 |
|
|
2023
Q3 | $552K | Buy |
5,898
+1,723
| +41% | +$161K | 0.26% | 94 |
|
|
2023
Q2 | $373K | Sell |
4,175
-3,163
| -43% | -$275K | 0.17% | 129 |
|
|
2023
Q1 | $787K | Hold |
7,338
| – | – | 0.64% | 50 |
|
|
2022
Q4 | $896K | Sell |
7,338
-2,442
| -25% | -$284K | 0.53% | 52 |
|
|
2022
Q3 | $1.01M | Buy |
9,780
+2,338
| +31% | +$222K | 0.58% | 43 |
|
|
2022
Q2 | $692K | Sell |
7,442
-379
| -5% | -$35.7K | 0.42% | 56 |
|
|
2022
Q1 | $918K | Sell |
7,821
-720
| -8% | -$83.4K | 0.58% | 41 |
|
|
2021
Q4 | $1.15M | Sell |
8,541
-1,228
| -13% | -$183K | 0.91% | 36 |
|
|
2021
Q3 | $1.56M | Buy |
9,769
+3,709
| +61% | +$508K | 1.03% | 17 |
|
|
2021
Q2 | $797K | Buy |
6,060
+555
| +10% | +$74K | 0.57% | 49 |
|
|
2021
Q1 | $709K | Buy |
5,505
+774
| +16% | +$118K | 0.53% | 38 |
|
|
2020
Q4 | $789K | Buy |
4,731
+1,424
| +43% | +$235K | 0.5% | 47 |
|
|
2020
Q3 | $510K | Buy |
3,307
+414
| +14% | +$59.5K | 0.37% | 48 |
|
|
2020
Q2 | $428K | Buy |
+2,893
| New | +$397K | 0.35% | 42 |
|
Other funds holding ASND
RCM
ACA
